Chantal LE FLOCH currently serves as Executive Director and Head of International Regulatory Affairs at Pfizer, a position held since January 2024. Prior to this role, Chantal led International Regulatory Affairs at Seagen from February 2022 to January 2024, overseeing regulatory strategies for clinical trials and medicinal product registrations in oncology. With extensive experience at Sanofi from January 2017 to February 2022, Chantal held various leadership roles in Global Regulatory Affairs, managing teams responsible for established and developmental products across multiple therapeutic areas within the EU region. Chantal's career includes a significant tenure at Servier, where leadership encompassed diverse regulatory functions and management of large teams in various departments. Educational qualifications include a Pharmaceutical Degree from Paris V, a Pharmaceutical Law Degree from Paris XI, a Hospital Pharmacist Degree in Manufacturing Quality Control, and an MBA in Marketing from IAE France.